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Background
According to the recommendations of the World Health Or-
ganization (WHO), infants known to have been exposed to 
the human immunodeficiency virus (HIV) should undergo a 
virological test for infection at 4 to 6 weeks of age.1,2 Antiret-
roviral therapy (ART) should be initiated upon diagnosis of 
HIV infection in children aged less than 24 months.3 However, 
implementing programmes for such early infant diagnosis and 
treatment has proved challenging.4–7
In Malawi, 13.8% of the children born to HIV-positive 
mothers in 2009 were themselves HIV-positive as infants,8 
but only 29% of those in need of ART received such treat-
ment.9 National guidelines in Malawi recommend that infants 
exposed to HIV be tested by polymerase chain reaction (PCR) 
for the detection of viral deoxyribonucleic acid (DNA) at 
6 weeks of age wherever the facilities and resources for these 
assays are available.10 In Malawi, as in several other countries, 
most early infant diagnosis is hospital-based and few infants 
receive ART after testing.8,11
We report here the experiences and challenges encoun-
tered during implementation of early infant diagnosis in two 
community health centres in Malawi.
Setting and approach
As part of recruitment procedures for a study assessing the 
impact of HIV infection on child neurodevelopmental pro-
cesses, early infant diagnosis services were established at two 
health-care facilities in Blantyre. One of these facilities, the 
Zingwangwa Health Centre, is an urban primary care centre 
that does not initiate or administer ART but that refers those 
in need of ART to a hospital. The other study facility, the 
Mlambe Mission Hospital, is located in a semi-rural area and 
serves as a primary and secondary care centre with on-site 
ART services. Both study facilities run programmes for the 
prevention of mother-to-child transmission (PMTCT) of 
HIV and both recommend breastfeeding and cotrimoxazole 
prophylaxis for all HIV-exposed infants.
As pregnant women and mothers with infants attended 
the study centres for PMTCT and postnatal visits, study staff 
explained to them the importance of early infant HIV diagno-
sis and the benefits of early ART for infants. To further increase 
awareness of early infant diagnosis, posters and brochures 
were distributed and community sensitization was performed. 
Each HIV-positive mother was given an appointment card. At 
6 weeks of age (or at the earliest visit thereafter), each infant 
of an HIV-positive mother was referred for cotrimoxazole 
prophylaxis and tested for HIV DNA. Permission for home 
visits was requested from the infant’s mother, who was asked 
to return with the infant, for a follow-up, 4 weeks later.
A sample of blood was collected from each HIV-exposed 
infant via a heel prick. These samples were transferred to 
Protein Saver 903® cards (Whatman Ltd, Piscataway, United 
States of America), which were then dried and individually 
packaged with desiccant sachets before being transported to 
the Malawi–Liverpool–Wellcome Trust research laboratory in 
Blantyre. At the laboratory, the dried blood spots on the cards 
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were tested for HIV DNA using version 
1.5 of the Amplicor® HIV-1 DNA test 
kit (Roche, Basel, Switzerland), which 
is based on a PCR. The laboratory 
included internal quality control pro-
cedures for each 4-weekly testing batch 
and participated in an external quality 
control programme run by the United 
States Centers for Disease Control and 
Prevention.
At follow-up, mothers of the chil-
dren found to be PCR-negative for 
HIV DNA were counselled on how to 
minimize transmission risk and the 
importance of repeat testing while 
breastfeeding. The mothers of the PCR-
positive infants were counselled on the 
importance of early infant ART and 
their infants were referred to the near-
est ART clinic. Community health staff, 
who were reimbursed by study funds, 
were asked to trace the mothers of PCR-
positive infants who did not return for 
the scheduled follow-up.
Attempts were made to retest each 
child who was initially found PCR-posi-
tive. In most cases, the same PCR-based 
assay as used initially was employed to 
test a second blood spot on the child’s 
6-week sample card. However, if the rel-
evant sample card could not be located, 
the HIV ribonucleic acid (RNA) in a 
second blood sample collected from the 
child was quantified, at the University 
of North Carolina’s project laboratory 
in Lilongwe, using version 1.5 of the 
Amplicor® HIV-1 Monitor (Roche). If 
the retest sample gave a positive result, 
the child was considered truly positive. 
If the retest sample appeared negative, 
another blood sample was collected 
from the child and either tested for HIV 
DNA or assayed for HIV RNA. If this 
sample was found negative, the child’s 
result was considered a false positive. 
The final result for any child who was 
found first positive and then negative 
and then was unavailable for a second 
retest was recorded as inconclusive.
Both the University of Malawi Col-
lege of Medicine Research and Ethics 
Committee and the University of North 
Carolina at Chapel Hill Institutional Re-
view Board approved the study protocol.
Results
Between January 2008 and June 2010, 
7234 women, of whom 1214 (16.8%; 
95% confidence interval, CI: 15.9%–
17.6%) were HIV-infected, participated 
in PMTCT activities at either of the two 
study centres. Although 920 (75.8%) of 
the infants of the HIV-positive moth-
ers presented for early infant diagnosis, 
consent for the necessary testing was 
only obtained from the mothers of 869 
(94.5%; 95% CI: 93.0%–95.9%) of these 
children. In consequence, only 71.6% 
(95% CI: 69.0%–74.1%) of the HIV-
exposed infants seen at the two study 
centres during the study period were 
tested for HIV DNA. Although all but 
one of the 50 women who declined to 
give consent for the infant testing said 
that they wanted to get permission from 
their spouses, none of these women 
ever returned for early infant diagnosis. 
Self-reported PMTCT coverage, for both 
mothers and infants at the two study 
sites, was 92.4%.
Overall, 126 (14.5%) of the 869 in-
fants tested for HIV DNA gave a positive 
initial result. The original sample cards 
for 61 of the PCR-positive children were 
relocated and another blood spot from 
each of these cards was checked for HIV 
DNA in the PCR-based assay. Of the 61 
children who were retested in this way, 
41 gave a positive result on retesting and 
20 gave a negative result. Although fresh 
blood samples were collected from 17 
of the 20 children found PCR-negative 
on retesting, only two of these 17 fresh 
samples gave a positive result when 
checked for HIV DNA (5 samples) or 
assayed for HIV RNA (12 samples). 
The original sample cards for 65 of 
the children who were initially found 
positive for HIV DNA had been thrown 
away after the initial testing. Fresh blood 
samples were obtained from 45 of these 
65 children and all 45 of these samples 
gave a positive result when assayed for 
HIV RNA. Confirmatory testing was not 
possible for the 20 children who were 
lost to follow-up. Among the 106 infants 
with any confirmatory testing, 88 were 
confirmed as HIV-infected and 15 were 
considered HIV-negative; the results for 
the remaining three children, who could 
not be retested fully, were inconclusive. 
Overall, 14.6% of the 103 children who 
were retested fully were found to have 
been falsely positive in the initial round 
of testing. The positive predictive value 
of the assay used in this initial round, 
which was based on the detection, by 
PCR, of HIV DNA in dried spots of 
blood from infants aged about 6 weeks, 
was therefore 85.4%.
Only 521 (60%) of the mothers 
of tested infants returned to the study 
centres to receive the results of the ini-
tial testing. However, compared with 
the other mothers of tested infants, a 
mother of a child found HIV-positive 
when first tested by PCR was signifi-
cantly more likely to have received the 
results of her infant’s test (87.3% versus 
55.3%; P < 0.0001). The initiation of 
ART was recorded for 51 children, who 
represented 58% of all of the children 
with confirmed HIV infection.
Discussion
Important lessons can be drawn from 
our experience (Box 1). Routine early 
infant diagnosis at the primary care level 
in a resource-poor setting is feasible but 
challenging, even when well supported 
by research funds. A strength of our 
approach was the integration of the 
early infant diagnosis programme into 
the existing PMTCT services, which 
facilitated delivery of messages about 
the importance and availability of early 
infant diagnosis and early ART to the 
target population of HIV-infected preg-
nant women. The scheduling of appoint-
ments for early infant diagnosis so that 
they coincided with routine visits for the 
vaccination of infants at 6 weeks of age 
eliminated the need for additional visits 
for the sole purpose of testing infants 
for early diagnosis. These approaches 
resulted in the HIV testing of more than 
two thirds of the HIV-exposed infants 
seen at the study centres.
Our experiences with the early 
infant diagnosis programme also high-
Box 1. Summary of main lessons learnt
•	 Integration of early infant diagnosis services with existing PMTCT services is feasible and 
facilitates delivery of messages about the importance of early infant diagnosis to HIV-
infected women.
•	 Despite active tracing of HIV-infected children, there are high rates of loss to follow-up at 
every stage of the early infant diagnosis programme.
•	 Improved diagnostic tools with point-of-care capacity are necessary to allow for more 
streamlined testing programmes with the potential for better linkage to infant antiretroviral 
treatment. 
HIV, human immunodeficiency virus; PMTCT, prevention of mother-to-child transmission.
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lighted many challenges. Unfortunately, 
since HIV exposure was not docu-
mented on the standard infant health 
passports and there was limited privacy 
in the clinics, it proved impossible to 
integrate the services for early infant 
diagnosis with vaccination clinics. 
The high percentage of false positive 
results in the initial round of HIV tests 
(14.6%) was unexpected, given the 
previously reported high specificity of 
the PCR-based assay that was used.12,13 
Further investigations indicated that 
laboratory contamination, resulting 
from the manual manipulation of the 
sample cards, was the most likely cause 
of the low specificity. This observation 
underscores the need for stringent qual-
ity control and confirmatory testing. The 
long delay between the collection of the 
initial blood samples and the availability 
of the results of confirmatory testing 
complicated the communication of an 
initial positive result and the manage-
ment of the children with such a result. 
Knowing the overwhelming benefits of 
early ART, we did not withhold such 
treatment until the confirmatory results 
were available. We carefully counselled 
the mothers of infants who were initially 
found PCR-positive while realizing that 
a positive result on an infant’s HIV test 
is devastating news and that the oc-
currence of false positive results can 
undermine community trust in early 
infant diagnosis.
The use of dried blood spots, which 
can be collected at any clinic and 
transported without refrigeration to 
a laboratory equipped for PCR-based 
analysis,12 has been an important step 
towards universal access to early infant 
diagnosis. However, by eliminating the 
need to transport samples or to return 
to a clinic to retrieve the test results, a 
rapid point-of-care test for infant HIV 
diagnosis14 could still greatly enhance 
the operational feasibility of early infant 
diagnosis programmes in resource-poor 
settings.
A unique aspect of our approach 
was the active tracing of HIV-positive 
infants, which resulted in the receipt 
of the infants’ HIV test results by the 
families of 87% of these infants. Trac-
ing is unlikely to be possible without 
dedicated funds. Sustainable strategies 
to improve the communication of test 
results to the caregivers of infants in 
routine settings need to be explored. 
Infant treatment programmes also need 
to be scaled up to maximize the number 
of HIV-infected infants who initiate 
ART – the ultimate goal of early infant 
diagnosis programmes.
While promising, the 71.6% cover-
age with early infant diagnostic services 
that was recorded in the present study 
indicates that one in four HIV-exposed 
infants did not access such services. Ad-
ditionally, the coverage recorded here 
may be an underestimate of the true 
value, since the 28% of women in Malawi 
who deliver at home, with the help of 
traditional birth attendants,15 may never 
be offered early infant diagnostic testing 
(Fig. 1). The involvement of traditional 
birth attendants in early infant diagno-
sis programmes and the integration of 
early infant diagnosis into vaccination 
clinics with community outreach could 
complement any clinic-based activities. 
The routine seeking of permission for 
infant testing from both the mother 
and her partner should be explored, as 
permission from the partner was the pri-
mary reason that women who presented 
for early infant diagnosis gave for not 
proceeding with the testing.
Although careful documentation 
and a large sample size were important 
strengths of this evaluation, the research 
setting limits the generalizability of our 
findings. The substantial human re-
sources and financial support that were 
available in the present study, through 
linkage with the research team, probably 
created a “best-case scenario” for a set-
ting that is usually resource-poor. Even 
under these conditions, however, the 
implementation of early infant diagnosis 
at the primary-care level was challeng-
ing, with the dropouts that occurred 
at every step diminishing the number 
of HIV-infected children who gained 
access to ART. Our experience suggests 
that, to maximize the benefits of early 
infant HIV diagnosis programmes, a 
simple, affordable and highly specific 
point-of-care test for infant HIV diag-
nosis and better linkage to care are both 
needed. ■
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Fig. 1. Opportunities to improve early infant diagnosis of HIV infection, based on 
experiences at two primary care centres, Malawi, 2008–2010
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ملخص
تنفيذ تشخيص عدوى فريوس العوز املناعي البرشي لدى الرضع يف مرحلة مبكرة عىل مستوى الرعاية األولية: التجارب 
والتحديات يف مالوي
بفحص  مالوي  يف  الوطنية  التوجيهية  املبادئ  تويص  املشكلة 
 )HIV( الرضع املعرضني لإلصابة بفريوس العوز املناعي البرشي
لدى  بالتشخيص  املعنية  اخلدمات  نرش  وكان  أسابيع.   6 سن  عند 
العالج بمضادات  بدء  الرضع يف مرحلة مبكرة حمدودًا ونتج عنه 
الفريوسات القهقرية )ART( لدى عدد قليل للغاية من األطفال.
مبكرة.  مرحلة  يف  الرضع  تشخيص  برنامج  إطالق  تم  األسلوب 
الرضع وتوعية  بشأن فحوص  السيدات احلوامل  تثقيف  وتضمن 
املجتمع املحيل وفحوص الرضع املجانية عند سن 6 أسابيع واقتفاء 
البرشي  املناعي  العوز  لفريوس  اإلجيابيني  للرضع  النشط  األثر 
واإلحالة للعالج والرعاية.
املواقع املحلية تم إنشاء الربنامج يف مرفقي رعاية أولية يف بالنتاير، 
بمالوي.
 1214 إمجايل  من   %  71.6 نسبة  خضعت  الصلة  ذات  ات  التغريرّ
إىل  البرشي  املناعي  العوز  بفريوس  لإلصابة  معرضني  رضيعًا 
تشخيص مبكر وكانت نتيجة فحص 14.5 % من الذين خضعوا 
للتشخيص املبكر إجيابية لفريوس العوز املناعي البرشي. وأكدت 
الفحوص اإلضافية التي خضع هلا 103 من 126 رضيعًا إجيابيني 
لفريوس العوز املناعي البرشي بشكل واضح عىل العدوى يف 88 
حالة؛ غري أن النتائج اخلمس عرشة األخرى كانت إجيابية عىل نحو 
زائف. وكان الختبار تفاعل البوليمرياز املتسلسل األويل لبقع الدم 
اجلافة قيمة تنبؤية إجيابية )PPV( بنسبة 85.4 %. وعىل الرغم من 
 )126/110(  %  87.3 سوى  إخبار  يتم  مل  النشط،  األثر  اقتفاء 
من أمهات الرضع الذين كانت النتيجة األولية لفحوصهم إجيابية 
الفريوسات  بمضادات  العالج  بدء  وتم   . الرضع  أطفاهلم  بنتائج 
بفريوس  إصابتهم  تأكد  الذين  الرضع  من   %  58 لدى  القهقرية 
العوز املناعي البرشي.
املناعي  العوز  فريوس  عدوى  تشخيص  يمثل  املستفادة  الدروس 
البرشي لدى الرضع يف مرحلة مبكرة عىل مستوى الرعاية األولية 
يف  األطفال  من  العديد  افتقد  وقد  حتديًا.  املوارد  فقرية  املواقع  يف 
إىل  وعالجه  البرشي  املناعي  العوز  فريوس  تشخيص  برنامج 
ذات  تشخيص  وسائل  توافر  وينبغي  متعددة.  مراحل  يف  املتابعة 
قيمة تنبؤية إجيابية وقدرة نقاط رعاية أعىل وحتسني البنية األساسية 
إلدارة العالج بمضادات الفريوسات القهقرية بغية حتسني التدبري 




























Mise en œuvre du diagnostic précoce de l’infection par le VIH des nourrissons, au niveau des soins primaires: expériences et 
défis au Malawi
Problème Les lignes directrices nationales du Malawi recommandent 
que les nourrissons exposés au virus de l’immunodéficience humaine 
(VIH) soient testés à l’âge de 6 semaines. Le déploiement des services 
pour le diagnostic précoce chez les nourrissons a été limité et n’a donné 
lieu au lancement de la thérapie antirétrovirale (TAR) que chez très peu 
de nourrissons.
Approche Un programme de diagnostic infantile précoce a été 
lancé. Il comprenait l’éducation des femmes enceintes quant aux tests 
des nourrissons, la sensibilisation des communautés, le test gratuit 
des nourrissons âgés de 6 semaines, le traçage actif des nourrissons 
séropositifs et l’aiguillage pour le traitement et les soins.
Environnement local Le programme a été établi dans deux 
établissements de soins de santé primaires à Blantyre, au Malawi.
Changements significatifs Sur 1 214 nourrissons exposés au VIH, 
71,6% bénéficiaient d’un diagnostic précoce, et 14,5% des nourrissons 
présentés étaient séropositifs. Des tests supplémentaires effectués sur 
103 de ces 126 nourrissons apparemment séropositifs ont confirmé 
l’infection de 88 d’entre eux; les 15 autres résultats étant faussement 
positifs. Les tests initiaux de réaction en chaîne par polymérase sur des 
taches de sang séché avaient une valeur prédictive positive (VPP) de 
85,4%. Malgré le traçage actif, seules 87,3% (110/126) des mères de 
nourrissons initialement testés positifs ont été informées des résultats 
des tests de leurs nourrissons. Un TAR a été initié chez 58% des 
nourrissons dont l’infection par le VIH a été confirmée.
Leçons tirées Le diagnostic précoce de l’infection par le VIH des 
nourrissons est un défi au niveau des soins primaires dans un contexte 
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de ressources limitées. Le suivi de nombreux enfants, dans le programme 
de diagnostic et de traitement du VIH, s’est interrompu à divers stades. 
Les outils de diagnostic avec une VPP et une capacité de lieu de soins 
plus élevées, et de meilleures infrastructures pour l’administration du 
TAR, sont nécessaires pour améliorer la prise en charge des nourrissons 
exposés et infectés par le VIH.
Резюме
Осуществление ранней диагностики ВИЧ-инфекции у младенцев на уровне первичной медицинской 
помощи: знания и задачи в Малави
Проблема Согласно национальным нормативам Малави, 
тестирование младенцев, подверженных вирусу иммунодефицита 
человека (ВИЧ), рекомендуется проводить в шестинедельном 
возрасте. Внедрение услуг по ранней диагностике инфекции 
у младенцев было ограничено, что привело к проведению 
антиретровирусной терапии (АРТ) у очень малого числа 
младенцев. 
Подход Произведен запуск программы по ранней диагностике 
инфекции у младенцев. Программа включала в себя 
информирование беременных женщин о тестировании 
младенцев, проведение разъяснительной работы среди 
местного населения, бесплатное тестирование младенцев 
шестинедельного возраста, активное наблюдение за ВИЧ-
положительными младенцами и направление их на лечение и 
уход.
Местные условия Программа реализовывалась в двух 
учреждениях первой медицинской помощи в г. Блантайр, Малави.
Соответствующие изменения Из 1214 младенцев, подверженных 
риску заражения ВИЧ, 71,6% направлялись на раннюю 
диагностику, и у 14,5% из числа направленных, результат на ВИЧ 
оказался положительным. Дальнейшее тестирование 103 из 126 
вероятно ВИЧ-положительных младенцев подтвердило наличие 
инфекции у 88 детей; остальные 15 результатов были ошибочно-
положительными. Положительное предсказательное значение 
(ППЗ) первоначального тестирования на основе полимеразной 
цепной реакции сухих капель крови составляло 85,4%. Несмотря 
на активное отслеживание, только 87,3% (110/126) матерям, чьи 
младенцы изначально имели положительные результаты, были 
сообщены результаты теста. АРТ проводилась у 58% младенцев 
с подтвержденной ВИЧ-инфекцией.
Извлеченные уроки Проведение ранней диагностики ВИЧ-
инфекции у младенцев на уровне первичной медицинской 
помощи в условиях нехватки ресурсов является затруднительным. 
Многие младенцы, участвовавшие в программе лечения и 
диагностики ВИЧ, выбывали из наблюдения на различных стадиях. 
Средства диагностики с высоким ППЗ и вместимость центров 
предоставления медицинских услуг и лучшая инфраструктура 
для назначения АРТ необходимы для улучшения ведения ВИЧ-
инфицированных младенцев и младенцев, подверженных риску 
заражения ВИЧ.
Resumen
La aplicación de un diagnóstico temprano de la infección por VIH en lactantes en el ámbito de la atención primaria: 
Experiencias y desafíos en Malawi
Situación Las directrices nacionales de Malawi recomiendan que se 
realice la prueba del virus de la inmunodeficiencia humana (VIH) a los 
lactantes expuestos al mismo cuando cumplan las 6 semanas de edad. 
Se ha restringido el desarrollo de los servicios de diagnóstico temprano 
de lactantes, lo que ha dado como resultado que muy pocos lactantes 
hayan comenzado con una terapia antirretroviral (TAR).
Enfoque Se lanzó un programa de diagnóstico temprano de lactantes 
que incluyó la formación de mujeres embarazadas acerca de las pruebas 
para lactantes, la sensibilización de la comunidad, pruebas gratuitas para 
lactantes de 6 semanas de edad, el seguimiento activo de lactantes 
seropositivos y la derivación para su tratamiento y atención sanitaria.
Marco regional El programa se estableció en dos centros de atención 
sanitaria primaria en Blantye, Malawi.
Cambios importantes De los 1214 lactantes expuestos, el 71,6% 
acudió al diagnóstico temprano y de ellos, el 14,5% dio positivo para 
el VIH. Otras pruebas realizadas a 103 de los, al parecer, 126 lactantes 
seropositivos confirmaron la infección en 88 lactantes, los otros 15 
resultados fueron falsos positivos. La reacción en cadena de la polimerasa 
inicial de muestras de sangre seca tuvo un valor predictivo positivo (VPP) 
del 85,4%. A pesar del seguimiento activo, sólo se comunicó el resultado 
de las pruebas al 87,3% (110/126) de las madres de lactantes que en un 
principio dieron positivo. La TAR se comenzó en el 58% de los lactantes 
con una infección por VIH confirmada.
Lecciones aprendidas El diagnóstico temprano para la infección 
por VIH en lactantes en el ámbito de la atención primaria en entornos 
con pocos recursos requiere un gran esfuerzo. En las distintas etapas 
se perdió el rastro de muchos niños del programa de diagnóstico y 
tratamiento del VIH. Las herramientas de diagnóstico con un VPP alto 
y la capacidad de los puntos de atención, así como la mejora de las 
infraestructuras para la administración de la TAR son necesarias para 
mejorar la gestión de los lactantes expuestos al VIH e infectados por él.
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